COPD Medication Study

Now Enrolling Adults Age 40 and Older

Now Enrolling

About this research study

Chronic obstructive pulmonary disease (COPD) is a group of diseases that cause airflow blockage and breathing problems. Symptoms of COPD include coughing or wheezing, shortness of breath, trouble taking a deep breath, and excess phlegm.

Velocity is now enrolling people for a study of an investigational medication for COPD in patients with COPD who have exertional breathlessness despite treatment with dual or triple COPD maintenance therapy.

Eligible participants...

  • Must be age 40 and older
  • Must have a diagnosis of COPD for at least a year
  • Must be a current or former smoker
  • Must be on dual or triple inhaled maintenance COPD treatment at a stable dose for the past 3 months
  • Must NOT have a current diagnosis of any other chronic respiratory diseases other than COPD
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Gaffney, South Carolina • Velocity Clinical Research

1529 N. Limestone Street, Gaffney, SC 29340
Phone: (864) 488-1283

Union, South Carolina • Velocity Clinical Research

1005 Thompson Blvd, Union, SC 29379
Phone: (864) 427-1172
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy